Skip to content

MAZE THERAPEUTICS, INC.

MAZE

CIK 0001842295

← back to feed
Revenue (TTM)
$187.5M
Q1 May 2026
Net Income (TTM)
−$120.76M
−351.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.03
−344.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-70.1%
Q1 May 2026
Net Margin
-64.4%
Q1 May 2026
Free Cash Flow (TTM)
−$112.73M
Q1 May 2026
Cash
$198.77M
Q1 May 2026
Total Debt
$38.83M
Q1 May 2026
Shares Outstanding
55.35M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings